stella
beta
Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC — Stella
Recruiting
Back to Nasopharyngeal Neoplasms trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
China
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian
Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian
Hainan General Hospital, Haikou, Hainan
View full record on ClinicalTrials.gov